These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 27256148)

  • 21. Changes in energy balance following smoking cessation and resumption of smoking in women.
    Perkins KA; Epstein LH; Pastor S
    J Consult Clin Psychol; 1990 Feb; 58(1):121-5. PubMed ID: 2319045
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of smoking cessation on caloric intake and weight gain in an inpatient unit.
    Leischow SJ; Stitzer ML
    Psychopharmacology (Berl); 1991; 104(4):522-6. PubMed ID: 1780423
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Smoking cessation and weight gain.
    Leischow SJ; Stitzer ML
    Br J Addict; 1991 May; 86(5):577-81. PubMed ID: 1859922
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Are we closer to finding the treatment for type 2 diabetes mellitus in morbid obesity? Are the incretins the key to success?
    Frezza EE
    Obes Surg; 2004 Aug; 14(7):999-1005. PubMed ID: 15329192
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Incretin hormones in the treatment of type 2 diabetes. Part I: influence of insulinotropic gut-derived hormones (incretins) on glucose metabolism].
    Matuszek B; Lenart-Lipińska M; Nowakowski A
    Endokrynol Pol; 2007; 58(6):522-8. PubMed ID: 18205109
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An alpha7 nicotinic acetylcholine receptor-selective agonist reduces weight gain and metabolic changes in a mouse model of diabetes.
    Marrero MB; Lucas R; Salet C; Hauser TA; Mazurov A; Lippiello PM; Bencherif M
    J Pharmacol Exp Ther; 2010 Jan; 332(1):173-80. PubMed ID: 19786623
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A randomized controlled trial of adding the nicotine patch to rimonabant for smoking cessation: efficacy, safety and weight gain.
    Rigotti NA; Gonzales D; Dale LC; Lawrence D; Chang Y;
    Addiction; 2009 Feb; 104(2):266-76. PubMed ID: 19149823
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Unimolecular dual incretins maximize metabolic benefits in rodents, monkeys, and humans.
    Finan B; Ma T; Ottaway N; Müller TD; Habegger KM; Heppner KM; Kirchner H; Holland J; Hembree J; Raver C; Lockie SH; Smiley DL; Gelfanov V; Yang B; Hofmann S; Bruemmer D; Drucker DJ; Pfluger PT; Perez-Tilve D; Gidda J; Vignati L; Zhang L; Hauptman JB; Lau M; Brecheisen M; Uhles S; Riboulet W; Hainaut E; Sebokova E; Conde-Knape K; Konkar A; DiMarchi RD; Tschöp MH
    Sci Transl Med; 2013 Oct; 5(209):209ra151. PubMed ID: 24174327
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Focus on incretin-based therapies: targeting the core defects of type 2 diabetes.
    Jellinger PS
    Postgrad Med; 2011 Jan; 123(1):53-65. PubMed ID: 21293084
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Weight gain after smoking cessation.
    Pistelli F; Aquilini F; Carrozzi L
    Monaldi Arch Chest Dis; 2009 Jun; 71(2):81-7. PubMed ID: 19719041
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of chronic cigarette smoking on body composition and fuel metabolism.
    Jensen EX; Fusch C; Jaeger P; Peheim E; Horber FF
    J Clin Endocrinol Metab; 1995 Jul; 80(7):2181-5. PubMed ID: 7608276
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Administration of an acylated GLP-1 and GIP preparation provides added beneficial glucose-lowering and insulinotropic actions over single incretins in mice with Type 2 diabetes and obesity.
    Gault VA; Kerr BD; Harriott P; Flatt PR
    Clin Sci (Lond); 2011 Aug; 121(3):107-17. PubMed ID: 21332446
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Smoking cessation and weight gain.
    Froom P; Melamed S; Benbassat J
    J Fam Pract; 1998 Jun; 46(6):460-4. PubMed ID: 9638109
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuro-modulation and bariatric surgery for type 2 diabetes mellitus.
    Spector D; Shikora S
    Int J Clin Pract Suppl; 2010 Feb; (166):53-8. PubMed ID: 20377665
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Smoking, insulin resistance and type 2 diabetes].
    Magis D; Geronooz I; Scheen AJ
    Rev Med Liege; 2002 Sep; 57(9):575-81. PubMed ID: 12440345
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma neuropeptide Y levels relate cigarette smoking and smoking cessation to body weight regulation.
    Hussain T; Al-Daghri NM; Al-Attas OS; Draz HM; Abd Al-Rahman SH; Yakout SM
    Regul Pept; 2012 Jun; 176(1-3):22-7. PubMed ID: 22387704
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incretins: pathophysiological and therapeutic implications of glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1.
    Ranganath LR
    J Clin Pathol; 2008 Apr; 61(4):401-9. PubMed ID: 18375745
    [TBL] [Abstract][Full Text] [Related]  

  • 38. GLP-1-derived nonapeptide GLP-1(28-36)amide inhibits weight gain and attenuates diabetes and hepatic steatosis in diet-induced obese mice.
    Tomas E; Wood JA; Stanojevic V; Habener JF
    Regul Pept; 2011 Aug; 169(1-3):43-8. PubMed ID: 21549160
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Strategies to minimize weight gain after smoking cessation: psychological and pharmacological intervention with specific reference to dexfenfluramine.
    Spring B; Pingitore R; Kessler K
    Int J Obes Relat Metab Disord; 1992 Dec; 16 Suppl 3():S19-23. PubMed ID: 1338318
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Energy intake and physical activity during short-term smoking cessation in postmenopausal women.
    Allen SS; Brintnell DM; Hatsukami D; Reich B
    Addict Behav; 2004 Jul; 29(5):947-51. PubMed ID: 15219340
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.